Baseline data from the UK arm of the REACH Registry

British Journal of Cardiology

Volumn 14, Issue 3, 2007, Pages 153-159

  Morell, Jonathan M ^a   Kassianos, George C ^b  

^a St Leonards on Sea   (United Kingdom)

^b Birch Hall Medical Centre ^*  (United Kingdom)

Author keywords

Atherothrombosis; Cerebrovascular disorders; Coronary disease; Peripheral vascular diseases; REACH; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; REGISTER; RISK ASSESSMENT; THROMBOSIS; UNITED KINGDOM; WESTERN EUROPE;

EID: 34447130482     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization. The World Health Report, 2002. Geneva: World Health Organization, 2002.
2. Guillot F, Moulard O. Epidemiological estimates of ischernic stroke and myocardial infarction (Abstract). Circulation 1998;98(suppl 1):1421.
3. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥ 62 years of age. Am J Cardiol 1994; 74:64-5.
4. Coccheri S. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: results from CAPRIE (Abstract). Eur Heart J 1998;19(suppl): 1288.
5. CAPRIE Steering Committee. A randomised, blinded, trial of clopiclogrel versus aspirin in subjects at risk of ischaernic events (CAPRIE). Lancet 1996;348:1229-39.
6. Newman AB, Shemanski L, Manolio TA et al. The Cardiovascular Health Study Collaborative Research Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study Arterioscler Thromb Vasc Biol 1999;19:538-45.
7. Lichtman JH, Krumholz HM, Wang Y et al. Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation 2002; 105:1082-7.
8. Vliegenthart R, Hollander M, Breteler MM et al. Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke 2002:33:462-5.
9. Vogt MT, McKenna M, Anderson SJ et al. The relationship between ankle-arm index and mortality in older men and women. J Am Genatr Soc 1993;41:523-30.
10. Dormandy JA, Creager MA. Ankle: arm blood pressure index as a predictor of atherothrombotic events: evidence from CAPRIE (abstract). Cerebrovasc Dis 1999;9(suppl 1): 1-128(Abstract 4).
11. Smith SC, Greenland P, Grundy SM. Prevention Conference V. Beyond secondary prevention: identifying the high-risk subject for primary prevention. Circulation 2000;101:111-16.
12. O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study 'Collaborative Research Group. N Engl J Med 1999;340:14-22.
13. Haffner SM, Lehto S, Rönnemmaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998:339:229-34.
14. The West of Scotland Coronary Prevention Study Group. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. Am J Cardiol 1997;79:756-62.
15. Intercollegiate Stroke Working Party. National clinical guidelines for stroke (2nd edn). London: Royal College of Physicians, June 2004.
16. Department of Health. National Service Framework for Coronary Heart Disease. London: Department of Health, March 2000.
17. TASC Working Group. Management of peripheral arterial disease: transatlantic intersociety consensus (TASC). Eur J Vasc Endovasc Surg 2000;19(suppl A):Sl-S244.
18. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-72.
19. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment, and control in the community: is the rule of halves still valid? J Human Hypertens 1997;1:213-20.
20. Ohman EM, Bhatt DL, Wilson PWF, Röther J, Steg PG; for REACH Registry Investigators. The REACH Registry: an international, prospective, observational investigation in subjects at risk of atherothrombotic events - study design. Am Heart J 2006; 151:786.e1-10.
21. Data on file. Sanofi-aventis, Guildford. UK.
22. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M et al. for the WHO MONICA Project. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 MONICA project populations. Lancet 1999;353:1547-57.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7-22.
24. BMA General Practitioners Committee and the NHS Confederation. Investing in General Practice. The New General Medical Services Contract. London: British Medical Association, 2003.
25. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004;18:139-85.
26. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary No. 50. London: BMJ Publishing Group and Royal Pharmaceutical Society of Great Britain, September 2005.
27. Bhatt DL, Steg PG, Ohman EM et al.; for the REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J Am Med Assoc 2006;295:180-9.
28. International Diabetes Federation. The Diabetes Atlas (2nd edn), Brussels: International Diabetes Federation, 2003.